Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to duloxetine versus escitalopram for residual apathy in major depressive disorder
2009-011837-29Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Duloxetine switch arm with Escitalopram switch arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2009; status: completed.
02
Drugs
duloxetineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2009-011837-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011837-29.